JO
BIOR

John Overdeck’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History

John Overdeck’s Portfolio BIOR Stock Details BIOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-3,699
Closed -$1.93M – 4732
2021
Q4 		$1.93M Buy
+3,699
New +$2.65M ﹤0.01% 1943

Other funds holding BIOR

ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

John Overdeck's BIOR Position: Q1 2022 in Review

John Overdeck sold out of Biora Therapeutics, Inc. Common Stock (BIOR) in Q1 2022, closing a stake of 3,699 shares — an estimated $1.93M sold.

John Overdeck first reported a position in BIOR in Q4 2021 and held it in 1 quarter. The position peaked at $1.93M in Q4 2021. 51 funds tracked by Wall St. Rank hold BIOR as of Q1 2022.

  • John Overdeck reported no remaining Biora Therapeutics, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • John Overdeck sold 3,699 Biora Therapeutics, Inc. Common Stock shares in Q1 2022, an estimated $1.93M.
  • John Overdeck first reported a position in Biora Therapeutics, Inc. Common Stock in Q4 2021 and held it in 1 quarter.
  • John Overdeck's Biora Therapeutics, Inc. Common Stock position peaked at $1.93M in Q4 2021.
  • 51 funds tracked by Wall St. Rank held Biora Therapeutics, Inc. Common Stock as of Q1 2022.

Based on Two Sigma Investments's 13F filing for Q1 2022, filed 16 May 2022.